Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1972 2
1973 2
1980 3
1981 3
1982 3
1984 2
1985 2
1986 1
1987 1
1988 2
1989 1
1990 1
1992 4
1993 2
1995 2
1996 1
1997 2
1998 2
2001 7
2002 1
2003 2
2004 1
2005 4
2006 3
2007 10
2008 2
2009 6
2010 8
2011 8
2012 8
2013 9
2014 3
2015 5
2016 9
2017 7
2018 13
2019 8
2020 9
2021 16
2022 10
2023 10
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

185 results

Results by year

Filters applied: . Clear all
Page 1
Vitreous hemorrhage - Causes, diagnosis, and management.
Shaikh N, Srishti R, Khanum A, Thirumalesh MB, Dave V, Arora A, Bansal R, Surve A, Azad S, Kumar V. Shaikh N, et al. Indian J Ophthalmol. 2023 Jan;71(1):28-38. doi: 10.4103/ijo.IJO_928_22. Indian J Ophthalmol. 2023. PMID: 36588205 Free PMC article. Review.
Vitreous hemorrhage is associated with a myriad of conditions such as proliferative diabetic retinopathy, proliferative retinopathy following vascular occlusion and vasculitis, trauma, retinal breaks, and posterior vitreous detachment without re …
Vitreous hemorrhage is associated with a myriad of conditions such as proliferative diabetic retinopathy, proliferat …
Diabetic retinopathy: Early diagnosis and effective treatment.
Kollias AN, Ulbig MW. Kollias AN, et al. Dtsch Arztebl Int. 2010 Feb;107(5):75-83; quiz 84. doi: 10.3238/arztebl.2010.0075. Epub 2010 Feb 5. Dtsch Arztebl Int. 2010. PMID: 20186318 Free PMC article. Review.
Two of its complications threaten the patient's vision: diabetic macular edema and proliferative diabetic retinopathy. METHODS: Selective literature review, based on national and international guidelines and a literature search from 1981 onward. RESULT …
Two of its complications threaten the patient's vision: diabetic macular edema and proliferative diabetic retinopath …
The progress in understanding and treatment of diabetic retinopathy.
Stitt AW, Curtis TM, Chen M, Medina RJ, McKay GJ, Jenkins A, Gardiner TA, Lyons TJ, Hammes HP, Simó R, Lois N. Stitt AW, et al. Prog Retin Eye Res. 2016 Mar;51:156-86. doi: 10.1016/j.preteyeres.2015.08.001. Epub 2015 Aug 18. Prog Retin Eye Res. 2016. PMID: 26297071 Review.
Furthermore, for people with proliferative diabetic retinopathy (PDR), laser photocoagulation remains a mainstay therapy, even though it is an inherently destructive procedure. This review summarises the clinical features of diabetic retinopa …
Furthermore, for people with proliferative diabetic retinopathy (PDR), laser photocoagulation remains a mainstay the …
A review of neovascular glaucoma. Etiopathogenesis and treatment.
Dumbrăveanu L, Cușnir V, Bobescu D. Dumbrăveanu L, et al. Rom J Ophthalmol. 2021 Oct-Dec;65(4):315-329. doi: 10.22336/rjo.2021.66. Rom J Ophthalmol. 2021. PMID: 35087972 Free PMC article. Review.
The most common causes of NVG are: central retinal vein occlusion, proliferative diabetic retinopathy, and ocular ischemic syndrome. Once the gonioscopy developed as a part of clinical examination, it became possible to visualize the new vessels of the anteri …
The most common causes of NVG are: central retinal vein occlusion, proliferative diabetic retinopathy, and ocular ische …
Recent advances in the management of proliferative diabetic retinopathy.
Pandit S, Ho AC, Yonekawa Y. Pandit S, et al. Curr Opin Ophthalmol. 2023 May 1;34(3):232-236. doi: 10.1097/ICU.0000000000000946. Epub 2023 Mar 3. Curr Opin Ophthalmol. 2023. PMID: 36866849 Review.
PURPOSE OF REVIEW: The prevalence of diabetic retinopathy continues to rise. This review highlights advances in imaging, medical, and surgical management of proliferative diabetic retinopathy (PDR) in recent years. RECENT FINDINGS: Ultra-widefie …
PURPOSE OF REVIEW: The prevalence of diabetic retinopathy continues to rise. This review highlights advances in imaging, medic …
Beyond VEGF: Targeting Inflammation and Other Pathways for Treatment of Retinal Disease.
Muniyandi A, Hartman GD, Song Y, Mijit M, Kelley MR, Corson TW. Muniyandi A, et al. J Pharmacol Exp Ther. 2023 Jul;386(1):15-25. doi: 10.1124/jpet.122.001563. Epub 2023 May 4. J Pharmacol Exp Ther. 2023. PMID: 37142441 Free PMC article. Review.
Neovascular eye diseases include conditions such as retinopathy of prematurity, proliferative diabetic retinopathy, and neovascular age-related macular degeneration. ...The affected signaling pathways illustrate the potential of new antiangiogenic stra …
Neovascular eye diseases include conditions such as retinopathy of prematurity, proliferative diabetic retinopathy …
Management of Complications and Vision Loss from Proliferative Diabetic Retinopathy.
Crabtree GS, Chang JS. Crabtree GS, et al. Curr Diab Rep. 2021 Sep 3;21(9):33. doi: 10.1007/s11892-021-01396-2. Curr Diab Rep. 2021. PMID: 34477996 Review.
RECENT FINDINGS: Advances in earlier treatment of proliferative diabetic retinopathy, especially with anti-VEGF injections, allow for a reduction in severity, improved vision, and more controlled and successful surgery. ...Over the last decade, anti-VEGF has …
RECENT FINDINGS: Advances in earlier treatment of proliferative diabetic retinopathy, especially with anti-VEGF injecti …
Current and investigational drugs for the treatment of diabetic retinopathy.
Tolentino MS, Tolentino AJ, Tolentino MJ. Tolentino MS, et al. Expert Opin Investig Drugs. 2016 Sep;25(9):1011-22. doi: 10.1080/13543784.2016.1201062. Epub 2016 Jul 1. Expert Opin Investig Drugs. 2016. PMID: 27367620 Review.
INTRODUCTION: Diabetic macular edema (DME) and proliferative diabetic retinopathy (PDR) are the two complications of diabetes that cause visual loss and blindness. ...However, diabetic retinopathy needs combination therapy. Ther …
INTRODUCTION: Diabetic macular edema (DME) and proliferative diabetic retinopathy (PDR) are the two complication …
Aflibercept for long-term treatment of diabetic macular edema and proliferative diabetic retinopathy: a meta-analysis.
Xie X, Lian C, Zhang Z, Feng M, Wang W, Yuan X, Shi Y, Liu T. Xie X, et al. Front Endocrinol (Lausanne). 2023 May 16;14:1144422. doi: 10.3389/fendo.2023.1144422. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37260449 Free PMC article. Review.
PURPOSE: This meta-analysis compared the long-term (12 months or 24 months) efficacy and safety of intravitreal aflibercept injection (IAI) for diabetic macular edema (DME) and proliferative diabetic retinopathy (PDR). ...
PURPOSE: This meta-analysis compared the long-term (12 months or 24 months) efficacy and safety of intravitreal aflibercept injection (IAI) …
Biologic Therapy and Treatment Options in Diabetic Retinopathy with Diabetic Macular Edema.
Nissen TPH, Vorum H, Aasbjerg K. Nissen TPH, et al. Curr Drug Saf. 2021;16(1):17-31. doi: 10.2174/1574886315666200902154322. Curr Drug Saf. 2021. PMID: 32881673 Review.
Proliferative diabetic retinopathy and diabetic macular edema can be a potentially sightthreatening disease if not treated correctly. ...This review aims to make an overview of the current pharmaceutical therapeutic options in the treatment of …
Proliferative diabetic retinopathy and diabetic macular edema can be a potentially sightthreatening disease if n …
185 results